Retail Investors Among Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited's (SHSE:600329) Largest Shareholders, Saw Gain in Holdings Value After Stock Jumped 31% Last Week

Simply Wall StSep 30 19:48 ET

Haleon Raising Stake in Tianjin TSKF Pharmaceutical JV to 88%

MT NewswiresSep 29 23:22 ET

Express News | Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited the Proposed Disposal of 13% Equity Interest in the Registered Capital of Tskf

ReutersSep 27 05:53 ET

tj darentang usd (600329.SH): Intends to transfer 13% and 20% equity held by the controlling shareholder in Tianjin Shike.

On September 27, Gelonhui announced that tj darentang usd (600329.SH) disclosed that the company and its controlling shareholder, Tianjin Pharmaceuticals Group Co., Ltd., intend to transfer their holdings of 13% and 20% equity respectively held in China and the United States Tianjin Stak Pharmaceutical Co., Ltd. to Heliang (China) Co., Ltd. The transaction prices are RMB 1,758,755,555.56 and RMB 2,705,777,777.78. Preliminary estimates indicate that this transaction is expected to generate an investment return of approximately RMB 1.7 billion.

Gelonghui FinanceSep 27 05:32 ET

Tianjin Pharmaceutical Da Ren Tang to Provide 832.7 Million Yuan Guarantee for Subsidiary

MT NewswiresSep 11 22:36 ET

tj darentang usd (600329.SH): It is proposed to inject the pharmaceutical subsidiary into the controlling shareholder's subsidiary, Taiping Company, in the form of capital increase.

Gelonghui September 11th | TJ Darentang (600329.SH) announced that in order to solve the issue of same industry competition between the listed company and the controlling shareholder, improve the profit indicators of the listed company, and further leverage the scale effect of the commercial sector, the company plans to transfer all equity of its wholly-owned subsidiary, Tianjin Zhongxin Pharmaceutical Co., Ltd. (referred to as "Pharmaceutical Company"), to the controlling shareholder Tianjin Pharmaceutical Group Co., Ltd. (referred to as "Pharmaceutical Group"), as consideration for capital increase, and incorporate it into the wholly-owned subsidiary Taiping Pharmaceutical Co., Ltd. (referred to as "Taiping Company") under Tianjin Pharmaceutical Group, and sign the "Jinyao Darentang Group Co., Ltd.

Gelonghui FinanceSep 11 05:22 ET